CN101972226B - 一种兽用盐酸多西环素注射液及其制备方法 - Google Patents
一种兽用盐酸多西环素注射液及其制备方法 Download PDFInfo
- Publication number
- CN101972226B CN101972226B CN 201010505729 CN201010505729A CN101972226B CN 101972226 B CN101972226 B CN 101972226B CN 201010505729 CN201010505729 CN 201010505729 CN 201010505729 A CN201010505729 A CN 201010505729A CN 101972226 B CN101972226 B CN 101972226B
- Authority
- CN
- China
- Prior art keywords
- doxycycline hydrochloride
- injection
- add
- trimethoprim
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PTNZGHXUZDHMIQ-UHFFFAOYSA-N 4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2C(C)C(C(O)C3C(C(O)=C(C(N)=O)C(=O)C3N(C)C)(O)C3=O)C3=C(O)C2=C1O PTNZGHXUZDHMIQ-UHFFFAOYSA-N 0.000 title claims abstract description 61
- 229960004082 doxycycline hydrochloride Drugs 0.000 title claims abstract description 61
- 238000002347 injection Methods 0.000 title claims abstract description 32
- 239000007924 injection Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title abstract description 10
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000006184 cosolvent Substances 0.000 claims abstract description 14
- 235000010265 sodium sulphite Nutrition 0.000 claims abstract description 12
- 239000008215 water for injection Substances 0.000 claims abstract description 12
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000010668 complexation reaction Methods 0.000 claims abstract description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 9
- 229910052938 sodium sulfate Inorganic materials 0.000 claims abstract description 9
- 235000011152 sodium sulphate Nutrition 0.000 claims abstract description 9
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 7
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 7
- 239000003960 organic solvent Substances 0.000 claims abstract description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 18
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 16
- 229960001082 trimethoprim Drugs 0.000 claims description 16
- 241001465754 Metazoa Species 0.000 claims description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- 235000019270 ammonium chloride Nutrition 0.000 claims description 9
- 238000005374 membrane filtration Methods 0.000 claims description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 8
- 239000002738 chelating agent Substances 0.000 claims description 7
- VYGBQXDNOUHIBZ-UHFFFAOYSA-L sodium formaldehyde sulphoxylate Chemical compound [Na+].[Na+].O=C.[O-]S[O-] VYGBQXDNOUHIBZ-UHFFFAOYSA-L 0.000 claims description 7
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 230000002421 anti-septic effect Effects 0.000 claims description 6
- 235000006708 antioxidants Nutrition 0.000 claims description 6
- -1 dimethoxy benzyl Aminometradine Chemical compound 0.000 claims description 5
- 229940074076 glycerol formal Drugs 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 229960001887 aminometradine Drugs 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 3
- 239000001527 calcium lactate Substances 0.000 claims description 3
- 229960002401 calcium lactate Drugs 0.000 claims description 3
- 235000011086 calcium lactate Nutrition 0.000 claims description 3
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000292 calcium oxide Substances 0.000 claims description 3
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 3
- 235000012255 calcium oxide Nutrition 0.000 claims description 3
- 239000011787 zinc oxide Substances 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 8
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- HAVPYQRGUSMFNA-UHFFFAOYSA-N n-benzyl-4-methoxypyrimidin-2-amine Chemical class COC1=CC=NC(NCC=2C=CC=CC=2)=N1 HAVPYQRGUSMFNA-UHFFFAOYSA-N 0.000 abstract 2
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000003285 pharmacodynamic effect Effects 0.000 abstract 1
- 229940090044 injection Drugs 0.000 description 21
- 229960005070 ascorbic acid Drugs 0.000 description 7
- 238000012856 packing Methods 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000004100 Oxytetracycline Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000003255 drug test Methods 0.000 description 2
- 229960000625 oxytetracycline Drugs 0.000 description 2
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 2
- 235000019366 oxytetracycline Nutrition 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 2
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 206010006500 Brucellosis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 206010039438 Salmonella Infections Diseases 0.000 description 1
- 241000193395 Sporosarcina pasteurii Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 229940031975 doxycycline injection Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 206010039447 salmonellosis Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 无效头数 | 有效头数 | 治愈率 |
空白对照组 | 20 | 0 | 0 |
药物对照组 | 8 | 12 | 60% |
药物试验组 | 4 | 16 | 80% |
组别 | 无效头数 | 有效头数 | 治愈率 |
实施例2 | 4 | 16 | 80% |
实施例3 | 5 | 15 | 75% |
实施例4 | 3 | 17 | 85% |
实施例5 | 3 | 17 | 85% |
实施例6 | 4 | 16 | 80% |
实施例7 | 2 | 18 | 90% |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010505729 CN101972226B (zh) | 2010-10-13 | 2010-10-13 | 一种兽用盐酸多西环素注射液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010505729 CN101972226B (zh) | 2010-10-13 | 2010-10-13 | 一种兽用盐酸多西环素注射液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101972226A CN101972226A (zh) | 2011-02-16 |
CN101972226B true CN101972226B (zh) | 2012-11-07 |
Family
ID=43572158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010505729 Expired - Fee Related CN101972226B (zh) | 2010-10-13 | 2010-10-13 | 一种兽用盐酸多西环素注射液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101972226B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2514647C1 (ru) * | 2013-04-23 | 2014-04-27 | Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" | Композиция для лечения инфекций бактериальной этиологии у животных |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102228462B (zh) * | 2011-05-13 | 2013-04-03 | 山东德州神牛药业有限公司 | 兽用土青注射液制备方法及临床应用 |
CN102813909B (zh) * | 2012-08-02 | 2014-10-22 | 青岛绿曼生物工程有限公司 | 防治家禽大肠杆菌病和慢性呼吸道疾病的复方盐酸多西环素组合物及其制备方法 |
CN102895245A (zh) * | 2012-10-30 | 2013-01-30 | 河南牧翔动物药业有限公司 | 一种复方甲氧苄啶与盐酸多西环素纳米乳制剂及其制备方法 |
CN105748404A (zh) * | 2015-05-12 | 2016-07-13 | 安徽省兽药研发中心 | 盐酸多西环素注射液及其制备工艺 |
CN110227063B (zh) * | 2019-06-18 | 2021-06-15 | 石药银湖制药有限公司 | 一种利奈唑胺注射液的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101062014A (zh) * | 2007-05-29 | 2007-10-31 | 江西省百思特动物药业有限公司 | 兽用复方盐酸多西环素注射液及其制备工艺 |
CN101062042A (zh) * | 2007-05-22 | 2007-10-31 | 江西核工业天地和药业有限公司 | 兽用复方长效土霉素注射液及其制备方法 |
CN101380301A (zh) * | 2008-10-28 | 2009-03-11 | 陈建波 | 兽用复方盐酸多西环素注射液及其制备方法 |
CN101804062A (zh) * | 2010-04-23 | 2010-08-18 | 镇江威特药业有限责任公司 | 兽用长效复方多西环素注射液及其制备方法 |
-
2010
- 2010-10-13 CN CN 201010505729 patent/CN101972226B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101062042A (zh) * | 2007-05-22 | 2007-10-31 | 江西核工业天地和药业有限公司 | 兽用复方长效土霉素注射液及其制备方法 |
CN101062014A (zh) * | 2007-05-29 | 2007-10-31 | 江西省百思特动物药业有限公司 | 兽用复方盐酸多西环素注射液及其制备工艺 |
CN101380301A (zh) * | 2008-10-28 | 2009-03-11 | 陈建波 | 兽用复方盐酸多西环素注射液及其制备方法 |
CN101804062A (zh) * | 2010-04-23 | 2010-08-18 | 镇江威特药业有限责任公司 | 兽用长效复方多西环素注射液及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2514647C1 (ru) * | 2013-04-23 | 2014-04-27 | Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" | Композиция для лечения инфекций бактериальной этиологии у животных |
Also Published As
Publication number | Publication date |
---|---|
CN101972226A (zh) | 2011-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101972226B (zh) | 一种兽用盐酸多西环素注射液及其制备方法 | |
CN100548305C (zh) | 兽用复方长效土霉素注射液及其制备方法 | |
CN102008490B (zh) | 兽用复方氟苯尼考注射液 | |
RU2414902C1 (ru) | Бактерицидная композиция для профилактики и лечения инфекционных заболеваний копыт у животных | |
CN104800167A (zh) | 一种氟苯尼考可溶性粉及其制备方法 | |
CN103143019B (zh) | 一种治疗猪传染性胸膜肺炎及呼吸道混合感染的复方制剂及其制备方法 | |
CN102258529B (zh) | 一种复方伊维菌素注射液及其制备方法 | |
CN103142990B (zh) | 一种治疗畜禽细菌性疾病的药物及其制备方法 | |
CN102784159B (zh) | 兽用注射用复方增效酒石酸泰乐菌素 | |
CN102000092B (zh) | 磺胺嘧啶钠在制备预防或治疗家蚕败血病药物中的用途 | |
CN101653448B (zh) | 兽用复方土霉素注射液及其制备方法 | |
CN102813909A (zh) | 防治家禽大肠杆菌病和慢性呼吸道疾病的复方盐酸多西环素组合物及其制备方法 | |
CN103405463A (zh) | 增效酒石酸泰乐菌素可溶性粉的复方药物制备方法 | |
CN103405465A (zh) | 用于治疗畜禽呼吸系统感染的药物的制备方法 | |
CN102784158B (zh) | 兽用注射用复方增效酒石酸泰乐菌素的制备方法 | |
RU2574025C2 (ru) | Препарат для лечения острых желудочно-кишечных болезней новорожденных ягнят | |
RU2563826C1 (ru) | Инъекционная антибактериальная фармацевтическая композиция | |
CN103405466B (zh) | 复方增效酒石酸泰乐菌素 | |
CN1985827B (zh) | 兽用复方环丙沙星注射液及其制备工艺 | |
RU2295332C2 (ru) | Препарат для лечения бактериальных и/или протозойных инфекций животных | |
RU2552912C1 (ru) | Способ повышения биоцидного действия в отношении бактерий, вирусов, патогенных грибов антисептика-стимулятора дорогова асд-2ф | |
RU2532349C1 (ru) | Комплексный препарат для лечения животных, больных бактериозами и дрожжевыми микозами | |
RU2564948C1 (ru) | Способ лечения эндометритов у коров | |
RU2514647C1 (ru) | Композиция для лечения инфекций бактериальной этиологии у животных | |
RU2251267C1 (ru) | Инсектицидный состав для борьбы с личинками оводов эга-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 451162 Zhengzhou economic comprehensive experimentation area, Zhengzhou air port, Henan, Xingang Province Patentee after: HENAN HOUYI INDUSTRIAL GROUP CO.,LTD. Address before: 451161, Henan, Zhengzhou, Xingang airport east side of the road Patentee before: ZHENGZHOU HOUYI PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211222 Address after: 463000 Zhumadian Industrial Park, Henan Province Patentee after: HENAN HOUYI PHARMACY CO.,LTD. Address before: 451162 Henan Zhengzhou Zhengzhou airport comprehensive economic experimentation area, Xingang Avenue East Patentee before: HENAN HOUYI INDUSTRIAL GROUP CO.,LTD. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121107 |